Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Veradermics, Inc
A clinical-stage biopharmaceutical company developing VDPHL01, an oral, non-hormonal extended-release form of minoxidil designed to grow hair while limiting heart-related side effects, for men and women with pattern hair loss. It was founded in 2019 by dermatologists who met at MIT's Hacking Dermatology competition, and its name blends the Latin for "true" with the Greek for "skin."
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
7.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
1.01 Entry into a Material Definitive Agreement · 3.02 Unregistered Sales of Equity Securities · 9.01 Financial Statements and Exhibits
7.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · 9.01 Financial Statements and Exhibits